# Dr. Brandon Essink – FDA Inspection, Feb 1, 2018

Source: https://www.keypedia.com/records/fda_inspections/dr-brandon-essink/33caef93-330a-48e9-b0fc-a0e275cf1db4
Source feed: FDA_Inspections

> FDA inspection 1044837 of Dr. Brandon Essink, February 01, 2018. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1044837
- Company Name: Dr. Brandon Essink
- Inspection Date: 2018-02-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1197334 - 2023-01-27
- [FDA Inspection 1046892 - 2018-03-15](https://www.keypedia.com/records/fda_inspections/dr-brandon-essink/dfc9d6ea-2325-4d18-90d8-5dec907e8a52)
- [FDA Inspection 769729 - 2012-02-24](https://www.keypedia.com/records/fda_inspections/dr-brandon-essink/f381f72f-9fac-42fa-9738-4b6fe04460cb)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/vickie-j-kanion/4ec38844-d90f-490e-bdfb-7bcee20fcc90)

Company: https://www.keypedia.com/companies/dr-brandon-essink/dfb3a883-bce7-4681-ae26-2e58163ce062

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
